The role of glucagon in the regulation of ketogenesis was reported by Gerich et al., who showed that suppression of glucagon, caused by the treatment with somatostatin, prevented the development of ketoacidosis in patients with type 1 diabetes mellitus after insulin withdrawal [69]. The gene discussed is GCG; the disease is type 1 diabetes mellitus.